NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-022-1997-0-PCT-02 Protease-Activatable Pseudomonas Exotoxin A-Like Proproteins PCT PCT PCT/US1997/020207 Expired
NCI E-022-1997-0-JP-06 MODIFIED PSEUDOMONAS EXOTOXIN PROPROTEINS JP National Stage 1998-521772 Abandoned
NCI E-022-1997-0-CA-05 MODIFIED PSEUDOMONAS EXOTOXIN PROPROTEINS CA National Stage 2271291 Abandoned
NIDDK E-227-1995-2-US-01 RNase L Activators and Antisense Oligonucleotides Effective to Treat RSV Infections US CIP 08/962,690 6214805 Abandoned PDF
NCI E-317-2000-0-US-01 Efficient Construction of Gene Targeting Vector. US ORD 08/963,602 6090554 Abandoned PDF
NIDA E-152-1996-0-PCT-02 SUSTAINED-RELEASE DERIVATIVES OF HYDROXYLATED ANALOGS OF SUBSTITUTED 1-[2[BIS(ARYL)METHOXY]ETHYL]-PIPERAZINES AND -HOMOPIPERAZINES AND THEIR USE AS NONCOMPETITIVE ANTAGONISTS OF DOPAMINE REUPTAKE PCT PCT PCT/US1997/019758 Expired
NIDA E-152-1996-0-JP-04 SUSTAINED-RELEASE DERIVATIVES OF HYDROXYLATED ANALOGS OF SUBSTITUTED 1-[2[BIS(ARYL)METHOXY]ETHYL]-PIPERAZINES AND -HOMOPIPERAZINES AND THEIR USE AS NONCOMPETITIVE ANTAGONISTS OF DOPAMINE REUPTAKE JP National Stage 1998-520775 Abandoned
NIDA E-152-1996-0-EP-05 SUBTAINED RELEASE DERIVATIVES OF HYDROXYLATED ANALOGS OF SUBSTITUTED 1-[2[BIS(ARYL)METHOXY]ETHYL]-PIPERAZINES AND -HOMOPIPERAZINES AND ... EP National Stage 97946401.3 Abandoned
NIDDK E-185-1999-0-US-01 Multispectral/ Hyperspectral Medical Instrument US 60/093,041 Abandoned
NIDA E-152-1996-0-CA-03 SUBTAINED RELEASE DERIVATIVES OF HYDROXYLATED ANALOGS OF SUBSTITUTED 1-[2[BIS(ARYL)METHOXY]ETHYL]-PIPERAZINES AND -HOMOPIPERAZINES AND ... CA National Stage 2269328 Abandoned
NCI E-347-2003-3-US-01 Humanized Anti-tag-72 Monoclonal Antibodies Using Human Subgroup 4 Kappa Light Chains US CIP 08/961,309 6495137 Expired PDF
NCI E-175-1996-0-US-02 GENETIC RESTRICTION OF HIV-1 INFECTION AND PROGRESSION TO AIDS BY A DELETION ALLELE OF THE CKR5 STRUCTURAL GENE US ORD 08/999,537 Abandoned
NCI E-283-1997-0-US-01 POSSESSION OF A NATURAL GENETIC VARIANT, SDF1-G801A, OF THE GENE ENCODING STROMAL DERIVED FACTOR IS ASSOCIATED WITH DELAY OF .... US 60/063,832 Abandoned
NIMH E-014-1997-0-AU-05 CHROMOSOMAL MARKERS AND DIAGNOSTIC TESTS FOR MANIC-DEPRESSIVE ILLNESS AU National Stage 51509/98 Abandoned
NCI E-116-2007-2-US-04 Self Assembled, Defective, Non-self Propagating Lentivirus Particles US DIV 08/958,906 6051410 Expired PDF
NIMH E-014-1997-0-PCT-02 CHROMOSOMAL MARKERS AND DIAGNOSTIC TESTS FOR MANIC-DEPRESSIVE ILLNESS PCT PCT PCT/US1997/019381 Expired
NHGRI E-004-1998-0-US-01 CDNA ENCODING A GENE ASSOCIATED WITH PENDRED SYNDROME, PDS, PENDRIN PROTEIN AND MUTATIONS ASSOCIATED THEREWITH US 60/063,309 Abandoned
NIMH E-014-1997-0-CA-04 CHROMOSOMAL MARKERS AND DIAGNOSTIC TESTS FOR MANIC-DEPRESSIVE ILLNESS CA National Stage 2241855 Abandoned
NCI E-009-1996-0-EP-04 METHODS AND COMPOSITIONS FOR INHIBITING INFLAMMATION AND ANGIOGENESIS EP National Stage 97946405.4 Abandoned
NCI E-009-1996-0-PCT-02 METHODS AND COMPOSITIONS FOR INHIBITING INFLAMMATION AND ANGIOGENESIS COMPRISING A MAMMALIAN CD97 ALPHA SUBUNIT PCT PCT PCT/US1997/019772 Expired
NCI E-009-1996-0-JP-05 METHODS AND COMPOSITIONS FOR INHIBITING INFLAMMATION AND ANGIOGENESIS JP National Stage 1998-519747 Abandoned
NCI E-009-1996-0-AU-03 METHODS AND COMPOSITIONS FOR INHIBITING INFLAMMATION AND ANGIOGENESIS AU National Stage 51580/98 Abandoned
NCI E-009-1996-0-CA-06 METHODS AND COMPOSITIONS FOR INHIBITING INFLAMMATION AND ANGIOGENESIS CA National Stage 2270154 Abandoned
NIAID E-222-1997-0-US-01 FUNCTIONAL PROMOTER FOR CCR5 US 60/065,934 Abandoned
NIDDK E-074-1998-0-US-01 Methods for Reducing Ischemic Injury of the Heart VIA the Sequential Administration of Momophosphoryl Lipid A and Adenosine Receptor Agents US 60/062,737 Abandoned
NCI E-231-1995-1-AU-14 METHODS OF IDENTIFYING PATIENTS HAVING AN ALTERED IMMUNE STATUS AU DIV 42829/97 Abandoned
NIAID E-072-1993-0-US-04 CLONING AND EXPRESSION OF PLASMODIUM FALCIPARUM TRANSMISSION-BLOCKING TARGET ANTIGEN, PFS230 US DIV 08/954,441 6316000 Abandoned PDF
NIDDK E-245-1992-0-US-04 ARALKYL DIAZABICYCLOALKANE DERIVATIVES FOR CNS DISORDERS US DIV 08/954,284 5958920 Abandoned PDF
NIMH E-121-1995-1-US-01 SUCEPTIBILITY AND RESISTANCE GENES FOR BIPOLAR AFFECTIVE DISORDER US 60/062,924 Abandoned
NIDDK E-174-1992-1-US-03 Chimeric Molecules Targeted to Viral RNAS US DIV 08/950,196 6271369 Abandoned PDF
NCI E-193-1997-0-US-01 RECOMBINANT ADENOVIRAL TARGETING VECTOR US 60/061,587 Abandoned
NIDDK E-073-1998-0-US-01 METHODS AND COMPOSITIONS FOR REDUCING ISCHEMIC INJURY OF THE HEART BY ADMINISTERING ADENOSINE RECEPTOR AGONISTS AND ANTAGONISTS US 60/061,716 Abandoned
NCI E-099-1996-0-US-01 Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA) US 60/061,589 Abandoned
NCI E-093-1993-0-AU-05 NOVEL IMMUNOTHERAPEUTIC METHODS AND VACCINES AU National Stage 40024/97 Abandoned
NCI E-196-1992-5-JP-07 POLYSACCHARIDE-BOUND NITRIC OXIDE-NUCLEOPHILE ADDUCTS JP DIV 2009-281020 Abandoned
NIDDK E-003-1995-0-CA-11 PREPARATION OF CHIRAL 5-AMINOCARBONYL-5H-DIBENZO[A,D]CYCLOHEPTEN-5, 10-IMINES BY OPTICAL RESOLUTION CA National Stage 2217877 Abandoned
NIDDK E-289-1997-0-US-01 METHOD OF PREVENTING NEPHROTOXICITY CAUSED BY CYCLOSPORINS US 60/062,947 Abandoned
NIDCR E-127-1995-2-PCT-01 ISOLATION AND METHOD OF USING TISSUE GROWTH-INDUCING FRZB PROTEIN PCT PCT COMB PCT/US1997/018362 Expired
NIMH E-011-1999-0-US-01 DIRECT USE OF TISSUE TO ISOLATE ANTI-HDS MODIFIED PHAGE US 60/061,446 Abandoned
NCI E-265-1997-0-US-01 NOVEL HUMAN CANCER ANTIGEN, CAG-3 AND GENE ENDOCING SAME US 60/061,428 Abandoned
NIMH E-012-1999-0-US-01 LONG CIRCULATING PHAGE VECTORS US 60/061,447 Abandoned
NIAID E-221-1997-0-US-01 CHIMERIC VACCINE AGAINST TICK-BORNE ENCEPHALITIS VIRUS US 60/061,441 Abandoned
NCI E-072-1995-0-US-02 SELECTIVE PREVENTION OF ORGAN INJURY IN SEPSIS AND SHOCK USING SELECTION RELEASE OF NITRIC OXIDE IN VULNERABLE ORGANS US DIV 08/942,896 5814656 Expired PDF
NCI E-210-1995-2-PCT-02 AN EPITHELIAL PROTEIN AND DNA THEREOF FOR USE IN EARLY CANCER DETECTION PCT PCT PCT/US1997/017714 Abandoned
NCI E-059-1996-0-PCT-02 INHIBITION OF HIV REPLICATION USING SOLUBLE TAT PEPTIDE ANALOGS PCT PCT PCT/US1997/017704 Expired
NIMH E-178-1996-1-US-01 THERAPEUTIC USE OF PHAGE EXPRESSING TOXIN-BINDING AND/OR CYTOKINE- BINDING PROTEINS US 60/060,881 Abandoned
NIMH E-178-1996-2-US-01 DELETION OF LYSOGENY GENES AND TOXIN GENES FROM BACTERIOPHAGE USED IN THE EPIDEMIOLOGIC CONTROL OF BACTERIAL ILLNESS US 60/060,879 Abandoned
NIAID E-102-1996-0-PCT-02 PFS25-28 FUSION PROTEINS PCT PCT PCT/US1997/017666 Abandoned
NCI E-103-1997-0-US-01 2-ALKOXY ESTRADIOL ANALOGS: ANTIANGIOGENIC AND ANTICANCER AGENTS US ORD 60/059,916 Abandoned
NCI E-093-1996-3-EP-19 O2-SUBSTITUTED 1-[(2-CARBOXYLATO) PYRROLIDIN -1-YL] DIAZEN-1-IUM-1, 2-DIOLATES EP DIV 10010885.1 Expired